Powered by

Chutes & Ladders—GSK vaccine exec Reichman splits to take biotech CEO post

Jan 22, 2021 - FierceBiotech
Board and Executive Moves

Amir Reichman, global vaccines engineering core technology at GSK, is stepping down to pursue a CEO role at BiondVax. Covance's Maryland Franklin is stepping up to run Covance's cell and gene therapy business. Francesco Marincola joins as head of cell therapy research at Kite.

Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please send the good word—or the bad—from your shop to Fraiser Kansteiner, and we will feature it h...